BLU — BELLUS Health Balance Sheet
0.000.00%
Last trade - 00:00HealthcareSpeculativeMid Cap
- CA$2.47bn
- CA$2.06bn
- $0.02m
Annual balance sheet for BELLUS Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | Interim Report | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 35.9 | 90 | 98.3 | 249 | 337 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.593 | 1.28 | 1.05 | 1.37 | 1.64 |
| Prepaid Expenses | |||||
| Total Current Assets | 37.3 | 94.2 | 102 | 258 | 356 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | 0.204 | 0.501 | 0.853 | 1.31 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 39.1 | 96.4 | 153 | 310 | 408 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.99 | 7.61 | 5.65 | 16.9 | 15.9 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 1.99 | 7.63 | 6 | 17.6 | 16.8 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 37.1 | 88.7 | 147 | 292 | 391 |
| Total Liabilities & Shareholders' Equity | 39.1 | 96.4 | 153 | 310 | 408 |
| Total Common Shares Outstanding |